BUZZ-Pfizer, BioNTech fall as GSK sues over COVID-19 vaccine technology

Reuters04-25

** Shares of vaccine makers Pfizer and BioNTech

fall between 2% to 3%

** Drugmaker GlaxoSmithKline sues BNTX and PFE accusing them of infringing its patents related to messenger RNA (mRNA) technology in the companies' blockbuster COVID-19 vaccines

** GSK says that PFE and BNTX's Comirnaty vaccines violate its patent rights in mRNA-vaccine innovations developed "more than a decade before" the outbreak of the COVID-19 pandemic

** GSK also asked the Delaware federal court for an unspecified amount of monetary damages from both companies that includes an ongoing patent-licensing fee

** A Pfizer spokesperson said in a statement that the company is "confident in our IP position around Comirnaty" and intends to "vigorously defend" against GSK's claims, while a BioNTech spokesperson declined to comment

** Including session moves, PFE down 11.3% and BNTX down 18.1% YTD

(Reporting by Sneha S K in Bengaluru)

((Sneha.SK@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment